Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

bioTheranostics develops and provides innovative oncology tests to support targeted disease management.

The bioT3 Metastatic Cancer Solution provides actionable genomic information for accurate diagnosis and treatment of metastatic cancer.

  • CancerTYPE ID® The most validated gene expression-based assay to help achieve an accurate diagnosis.
    Learn More >
  • CancerTREATMENT NGS+ Combines Next Generation Sequencing (NGS) with selected IHC/FISH tests to identify biomarkers linked to targeted treatments.
    Learn More >

Breast Cancer IndexSM (BCI) provides full risk assessment, with the unique ability to predict both early and late recurrence, as well as likelihood of benefit from extended endocrine therapy.
Learn More >